ICBII Overcomes the Challenge of Enabling Drugs to Reach Brain Cells
Innovative California Biosciences International, Inc., A private Biotech company based in La Jolla, CA has profoundly succeeded in the development of proprietary antibody mimics; the SMART Molecules, which are said to diagnose and treat diseases of the Central Nervous System in humans. This opens the road for endless possibilities to cure brain-related diseases and even cancers of all types in the near future. Around 60 million people suffer from diseases of the Central Nervous System like Alzheimer’s (AD), Parkinson’s (PD), and Multiple Systems Atrophy (MSA-P) worldwide. Parkinson's disease is a result of nerve cells malfunctioning inside the brain. Alzheimer's disease (AD), which is common among older adults, is an irreversible degeneration of the brain that disrupts memory, basic cognition and function leading to death from complete brain failure. These individuals are deprived of even the basic human functionality. To date, there are no methods for diagnosing and ha